Clade

Developer of stem cell-derived therapies for cancer treatment

placeCambridge, Massachusetts, United States calendar_todayFounded 2020 groups13 employees language cladetx.com

Registered entities

Investor mix

4 investors on record; lead investors include Syncona.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%
Coming soon